Elevecta Finance Analyst at Danaher Corporation

Cologne, North Rhine-Westphalia, Germany

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Life Sciences, Biotechnology, GenomicsIndustries

Requirements

Bachelor’s degree in accounting, finance, or business administration and minimum of 3 years of financial work experience developing forecasts and operating plans
Working in a global business environment with strong understanding of Accounting Principles, Controllership (i.e. SOX, US GAAP), and operational processes
Strong skills in financial systems / applications (i.e. Oracle, Qlik, Power BI, etc.) for reporting and business intelligence, and expert skills in Microsoft Excel for data compilation and aggregation (i.e. pivot tables, vlookup, power queries, and macros)
Excellent communication skills to clearly communicate complex financial information in an easy-to-understand manner both verbally and written
Fluent in English and German languages is mandatory
Previous experience in Finance / FP&A within international organizations in the Life Sciences / Healthcare industry (plus)
Experience successfully leading cross-functional projects and process improvement within the operations/finance functions being able to quickly grasp new ideas and drive positive change (plus)

Responsibilities

Lead the annual planning and monthly forecasting cycles
Prepare and report monthly actuals and forecasts to the Genomic Medicine Finance team
Act as the main partner for the broader Elevecta Leadership team
Conduct Financial Planning and Analysis activities including forecasting and actuals variance analysis
Develop and maintain performance KPIs to drive growth and profitability for Elevecta’s portfolio, including orders, sales, pricing, margin, and market share; frequently present the analysis of actuals vs plan
Monitor the progress on agreed initiatives, through relevant KPIs and Risks & Opportunities, to pro-actively recommend mitigation actions for any deviations from target performance metrics
Maintain a culture of control, compliance, and appropriate record keeping with regards to financial controls within local and Cytiva standards supporting the statutory account and specific legal entity requirements

Skills

Financial Planning

Forecasting

Variance Analysis

KPI Development

Financial Reporting

Pricing Analysis

Margin Analysis

Market Share Analysis

Risk Management

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters

1969Year Founded

IPOCompany Stage

Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries

10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.

Potential regulatory challenges in the EU for water quality sector.

Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.

The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.

Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.

Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.

Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI

Try Jobo Free